... Mar 20
As Biovet prepares for commercial distribution, the widespread use of Biolumpivaxin will reshape India’s battle against LSD and set an example for disease control ... Feb 10
From its humble beginning in Bhubaneswar to its recognition on the global stage, the startup embodies the spirit of India’s biotechnology revolution.... Jan 28
Regulatory approvals, market penetration, and public awareness are critical factors that will determine the success of ErlySign’s innovation. ... Jan 17
While the drug continues to be available in India, the emphasis on safety measures reflects a commitment to protecting public health.... Dec 23
As this indigenous antibiotic becomes available, it carries with it the promise of a healthier future, a future where pneumonia and other drug-resistant infections ... Dec 05
This development not only strengthens India’s regulatory framework but also positions the country as a key player in the global medical technology market.... Oct 05
Rigorous testing, strict regulatory oversight, and public education are key to safeguarding public health and restoring trust in the system.... Sep 25
These kits have also been designed to adhere to Indian statutory guidelines while complying with the highest global standards, ensuring that they meet both national ... Aug 29
This research was a collaborative effort involving experts from Newcastle University, the Indian Institute of Public Health - Delhi, Queen Mary University of London, and other ... Aug 23
India has all the essential ingredients for exponential growth in HealthTech and MedTech. These include a large population, a robust pharma and medical supply chain, ... Jul 12
The new drug discovery needs 10 to 15 years, and a lot of money—2bn US $ and even after that, the probability of success is ... May 24
The future of OTC drugs in India looks promising, with the potential to make a substantial positive impact on public health.... May 18
A simple to initiate once-daily solution that breaks through the complexity of living with type 2 diabetes. Nominal therapy cost enables wider access to ... Apr 30
It is essential for all involved parties to adhere to these guidelines to prevent the introduction of sub-standard products into the market and uphold ... Apr 19
This innovative approach not only offers advanced therapeutic options to cancer patients but also addresses the affordability and accessibility challenges associated with life-saving treatments. ... Dec 06
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings .... Oct 31
Medical devices Manufacturers have a new guideline, The Central Drugs Standard Organization (CDSCO) issued a new deadline of October 1, for the categorized medical devices ... Oct 09
WHO (World Health Organization) made an alert on the manufacture of Made-in-India medicines such as cough syrups and vitamins that were linked to ... Jun 21
Dry AMD is the largest cause of incurable blindness in people above 60 and affects roughly 170 million people worldwide.The investment will allow Eyestem ... Aug 11
The investment will allow Eyestem to progress a treatment for Dry Age-related Macular Degeneration into clinical trials. ... Aug 08
CoviEasy has undergone stringent quality checks at the Indian Council of Medical Research (ICMR) approved validation centre and further received approval from the Drugs Controller ... Jun 17
... May 20
The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between ... Apr 26
PM Narendra Modi said that government will bear the cost of 3 crore vaccination for frontline workers... Jan 12
-Advertisements-
.jpeg)
Monday, April 07, 2025
.jpeg)
.jpeg)
.jpeg)
.jpeg)
